AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY POSITION STATEMENT ON THYROID...

Area of Science:

• Endocrinology
• Internal Medicine
• Preventive Medicine

Background:

• Thyroid dysfunction, including hypothyroidism and hyperthyroidism, is safely and cost-effectively diagnosable and treatable.
• Recent United States Preventive Services Task Force guidelines do not recommend screening for thyroid dysfunction due to unproven benefits and potential harms of treating subclinical disease.
• The American Association of Clinical Endocrinologists (AACE) expresses concern that these guidelines may discourage clinically appropriate thyroid testing.

Purpose of the Study:

• To differentiate between screening and case-based testing for thyroid dysfunction.
• To advocate for an aggressive case-finding approach in clinical practice.
• To emphasize the importance of biochemical confirmation for diagnosing thyroid disease due to nonspecific symptoms.

Main Methods:

• This White Paper highlights the distinction between population-based screening and individualized case-finding.
• It reviews current guidance on thyroid-stimulating hormone testing.
• It emphasizes clinical judgment in identifying patients likely to benefit from thyroid disease treatment.

Main Results:

• Nonspecific symptoms frequently encountered in clinical practice may indicate underlying thyroid dysfunction.
• Accurate diagnosis is crucial for the successful application of safe and effective thyroid disorder interventions.
• Biochemical confirmation is necessary for diagnosing thyroid disease, given the lack of symptom specificity.

Conclusions:

• Thyroid dysfunction should be considered a potential cause of various nonspecific patient complaints.
• An aggressive case-finding strategy is recommended to identify individuals who would benefit from thyroid disease treatment.
• The AACE advocates for proactive case identification over broad screening to ensure appropriate diagnosis and management of thyroid disorders.